FDA Approves Home Glaucoma Devices; Survey Highlights Cost Barriers
1 report, 1 independent
Updated Oct 13
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
The FDA approved home tonometry devices, specifically iCare Home and iCare Home2, made by iCare Oy. Concurrently, the American Glaucoma Society conducted a physician survey. The survey found that while these devices increased doctor confidence and influenced clinical management, financial cost and skepticism about reliability remain major barriers to widespread use.
From healio.com
Why it matters
The approval expands the market for at-home glaucoma monitoring. However, the reported financial cost and lack of broad clinical integration suggest that adoption rates may be limited despite the technology's potential.
From healio.com
Who's involved
- FDARegulatory agency that approved home tonometry devices.
- American Glaucoma SocietyOrganization that conducted a physician survey on home tonometry use.
- Center for Devices and Radiological HealthFormal division of the FDA that issues alerts and holds meetings.